Publications by authors named "S Reitter-Pfoertner"

Purpose: to quantify and compare pre- and post-surgical incontinence pad use between men treated with radical prostatectomy (RP) for prostate cancer (PCa) and cancer-free controls, using population-based Austrian insurance claims data.

Methods: Men who underwent RP for treating PCa between 2013-2015 were identified. Cancer-free men ≥45 years with and without benign prostate hyperplasia (BPH) were used as controls.

View Article and Find Full Text PDF
Article Synopsis
  • * The majority of patients are middle-aged (median age 34 years), with 39% having severe haemophilia, and there are notable health concerns as 38.4% of those with severe cases have HCV and 12.6% have HIV.
  • * Treatment approaches show that 68.4% of patients with severe haemophilia are on prophylactic therapy, with many using recombinant products, highlighting ongoing challenges with infections and treatment strategies in this population. *
View Article and Find Full Text PDF

Background: Nowadays patients with haemophilia survive longer due to improvements in haemophilia care. It has been hypothesized that the bleeding type and frequency may vary with age and are influenced by co-morbidities and co-medication in elderly patients.

Objectives: To investigate a large group of patients older than 60 years of age with haemophilia concerning haemophilia treatment, bleeding pattern changes, co-morbidities, co-medication, bleeding sites and patient mortality.

View Article and Find Full Text PDF

Unlabelled: Essentials Data on bleeding-related causes of death in non-severe hemophilia A (HA) patients are scarce. Such data may provide new insights into areas of care that can be improved. Non-severe HA patients have an increased risk of dying from intracranial bleeding.

View Article and Find Full Text PDF

The substantial variability in pharmacokinetic parameters in hemophilia patients A poses a challenge for optimal treatment with factor VIII (FVIII) products. We investigated the effect of FVIII-specific immunoglobulin G (IgG) on FVIII half-life in a cohort of 42 adult patients with severe and moderate hemophilia A without inhibitors. Fifteen (35.

View Article and Find Full Text PDF